pharmaceutical news

Receive free subspecialty "5-minute updates" via email Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration
Annals of Pharmacotherapy, 09/25/09

Sponsor

Anti-Cancer Agent Xeloda and Avastin Obtained Approval for Additional Indication of Colorectal Cancer
Chugai Pharmaceutical Co., 09/25/09 Free full text Sandoz completes acquisition of EBEWE Pharma, improving global patient access to affordable injectable cancer medicines
Novartis, 09/25/09 Free full text New Data Support Safety of Aquacel Ag Dressing
Wounds, 09/25/09 Results from Abbotts PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease
Abbott, 09/25/09 Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
Cephalon, 09/25/09 Free full text Docs Use RHIO to Access Images
HealthDataManagement, 09/25/09 Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in First-Line Metastatic Colorectal Cancer
Amgen, 09/25/09 Free full text Herceptin provides impressive survival benefit for patients with high levels of HER2 in their stomach cancer
Roche, 09/25/09 Free full text Results Of Adagio Study With Azilect In Parkinson's Disease Published In New England Journal Of Medicine
Teva Pharmaceutical Industries, 09/25/09 Free full text Ticagrelor reduced cardiovascular deaths and heart attacks in ACS patients undergoing heart procedures: New data from PLATO trial
AstraZeneca, 09/25/09 Free full text Merck Statement on HIV Vaccine Trial
Merck & Co., 09/25/09 Free full text Teva Provides Update On Generic Evista Litigation
Teva Pharmaceutical Industries, 09/25/09 Free full text BTG plc: Campath Meets Primary Endpoint in Phase III Combination Therapy Trial for Chronic Lymphocytic Leukemia
BTG, 09/25/09 Free full text Sanofi Pasteur Commends Results of First HIV Vaccine Study to Show Some Effectiveness in Preventing HIV
Sanofi-aventis, 09/25/09 Free full text Continuous improvements in animal welfare within Roche Research
Roche, 09/25/09 Free full text OPAXIO Phase II Trial in Esophageal Cancer to be Presented in Proffered Session at the International Society of Gastrointestinal Oncology Annual Meeting
Cell Therapeutics, 09/25/09 Free full text Genzyme’s Campath Meets Primary Endpoint in Phase 3 Combination Therapy Trial for Chronic Lymphocytic Leukemia
Genzyme, 09/25/09 Free full text Farletuzumab Data Presented on Phase II Clinical Trial in First-Relapsed Ovarian Cancer Subjects
Morphotek, 09/25/09 Free full text Dendreon Reports PROVENGE Regulatory and Commercialization Progress and Future Pipeline Plans at Analyst Event
Dendreon Coproration, 09/25/09 Free full text